USPTO to Reexamine ExonHit Therapeutics Patent
Patent Docs: By Donald Zuhn — Last month, Larkspur, California-based biotech Jivan Biologics, Inc. announced that the U.S. Patent and Trademark Office had granted its request for an ex parte reexamination of U.S. Patent No. 6,881,571, which is owned by ExonHit Therapeutics S.A. The ‘571 patent is directed to devices for identifying…